Current Medicine Around the World
2022 - July
Outcomes of Sacrococcygeal Teratoma: An 18-year Experience in a Single Tertiary Referral Center in Thailand
Nutnicha Suksamanapun, Prapaporn Uthedphonrattanagul, Mongkol Laohapensang, Monawat Ngerncham
Current Medicine Around the World, 2022 - July
Article DOI: 10.21614/sgo-eC-392
Pediatric sacrococcygeal teratoma (SCT), yet a rare tumor, is a common solid tumor among neonates. Although overall survival is excellent, tumor recurrence may compromise the outcomes.
Objectives: The aim of this study is to determine overall survival rate, tumor recurrence rate, and associated factors for recurrence. Materials and

Methods: A retrospective chart review of patients admitted to Siriraj Hospital with SCT (2000-2018) was performed. Data were collected and analyzed for the association with outcomes, including survival rate, and tumor recurrence.

Results: Forty-one patients were included. Overall survival was 95.1%. Two patients died, one due to bleeding from perinatal tumors rupture and the other due to post-chemotherapy complications. Twenty-three patients who achieved at least 3-year period of follow-up. Among those, 2 patients developed recurrences which were significantly associated with late presentation, small tumor size, potentially malignant histology, and Altman type IV. Overall bowel or bladder dysfunctions were found in 8 patients.

Conclusion: Overall survival in SCTs was excellence. Recurrence occurred at 8.6%. However, it did not negatively influence the survival rate. Early diagnosis and complete tumor removal including the coccyx are crucial for minimizing tumor recurrence. Long-term follow-up and prompt intervention might improve outcomes of recurrent disease.

Full Text Sources: Download pdf
Abstract:   Abstract EN
Views: 1708


Watch Video Articles


For Authors



Journal Subscriptions

Current Issue

Jun 2025

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2025
Meetings and Courses in 2024
Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/
Publisher’s Note:
The opinions, statements, and data contained in article are solely those of the authors and not of Surgery, Gastroenterology and Oncology journal or the editors. Publisher and the editors disclaim responsibility for any damage resulting from any ideas, instructions, methods, or products referred to in the content.